TELA Bio (TELA) Stock Analysis & Winston Score

TELA Bio makes surgical mesh products used to repair soft tissue, like hernias and abdominal wall defects. Its main product is OviTex, a mesh made from a combination of synthetic material and biological tissue derived from sheep. Surgeons at hospitals across the United States use these products during reconstructive surgeries.

The company sells its products directly to hospitals and surgical centers, earning revenue each time a product is used in a procedure. TELA Bio operates almost entirely in the United States and is a small company still in growth mode, with annual revenue in the range of roughly $100 million. Its differentiated material technology gives it some separation from standard synthetic or purely biological mesh competitors, but the company is not yet profitable and burns cash to fund its sales force expansion. The biggest risk is that it must keep growing procedure volume fast enough to reach profitability before needing to raise additional capital.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.9% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+16.0% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

26.5%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$40M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

TELA Bio is growing revenue at 3% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

65.7%

Premium pricing power — 65.7% gross margin

Operating Margin

-55.2%

Losing money on operations — -55.2%

ROCE

-20.8%

Weak — -20.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+13.5%

Fast-growing sales (13.5% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-23.4%

Burning cash (-23.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial